REFERENCES
- Biskobing D M. COPD and osteoporosis. Chest 2002; 121: 609–620
- Goldstein M F, Fallon J J, Jr, Harning R. Chronic glucocorticoid therapy-induce osteoporosis in patients with obstructive lung disease. Chest 1999; 116: 1733–1749
- National Institues of Health Consensus Development Panel on Osteoporosis. Prevention, diagnosis, and therapy. JAMA 2001; 285: 785–795
- Seeman E., Wagner H, Offord K, Kumar R, Johnson W, Riggs B. Differential effects of endocrine dysfunction on the axial and appendicular skeleton. J Clin Invest 1982; 69: 1302–1309
- NHLBI/WHO. Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop report: global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2005, Available at: http://www.goldcopd.com Accessed November 11, 2005
- Celli B R, Cote C G, Marin J M, Casanova C, Montes de Oca M, Mendez R A, Plata V P, Cabral H J. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in Chronic Obstructive Pulmonary Disease. N Engl J Med 2004; 350: 1005–1012
- American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991; 144: 1202–1218
- American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995; 152: 1107–1136
- American Thoracic Society. Single-breath carbon monoxide diffusing capacity (transfer factor): recommendations for a standard technique–1995 update. Am J Respir Crit Care Med 1995; 152: 2185–2198
- Crapo R O, Morris A H, Gardner R M. Reference spirometric values using techniques and equipment that meets ATS recommendations. Am Rev Respir Dis 1981; 123(6)659–664
- American Thoracic Society. ATS Statement: Guidelines for the Six-Minute Walk Test. Am J Respir Crit Care Med 2002; 166: 111–117
- Weinstein M S, Martin U J, Crookshank A D, Chatila W, Vance G B, Gaughan J P, Furukawa S, Criner G J. Mortality and functional performance in severe emphysema after lung volume reduction or transplant. COPD, (In press)
- Iqbal F, Michaelson J, Thaler L, et al. Declining bone mass in men with chronic pulmonary disease: contribution of glucocorticoid treatment, body mass index, and gonadal function. Chest 1999; 116: 1616–1624
- Eastell R. Treatment of postmenopausal osteoporosis. N Engl J Med 1998; 338: 736–746
- Ionescu A A, Schoon E. Osteoporosis in chronic obstructive pulmonary disease. Eur Respir J Suppl Nov, 2003; 46: 64s–75s
- Tschopp O, Boehler A, Speich R, Weder W, Seifert B, Russ E W, Schmid C. Osteoporosis before lung transplantation: association with low body mass index, but not with underlying disease. Am J Transplant Feb, 2002; 2(2)167–172
- Shane E, Silverberg S J, Donovan D, Papadopoulos A, Staron R B, Addesso V, Jorgesen B, McGregor C, Schulman L. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease. Amer J Med 1996; 101(3)262–269
- National Institues of Health Consensus Development Panel on Osteoporosis. Prevention, diagnosis, and therapy. JAMA 2001; 285: 785–795
- Sin D. The risk of osteoporosis in caucasian men and women with Obstructive Airways Disease. Amer J Med 2003; 114: 10–14
- Mc Evoy C E, Ensrud K E, Bender E, Harry K. Association between corticosteroid use and vertebral fractures in older men with Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 1998; 157(3)704–709
- Looker A C, Orwoll E S, Johnston C C, Jr, Lindsay R L, Wahner H W, Dunn W L, Calvo M S, Harris T B, Heyse S P. Prevalence of low femoral bone density in older U.S. adults from NHANES III. J Bone Miner Res 1997; 12: 1761–1768
- Vrieze A, de Greef M H, Wýkstra P J, Wempe J B. Low bone mineral density in COPD patients related to worse lung function, low weight and decreased fat-free mass. Osteoporosis Int 2007, March 9
- Margolis K L, Ensrud K E, Schreiner P J, Tabor H K. Body size and risk for clinical fractures in old women. Study of Osteoporotic Fractures Research Group. Ann Intern Med 2000; 133: 123–127
- Katsura H, Kida K. A comparison of bone mineral density in elderly female patients with COPD and bronchial asthma. Chest 2002; 122: 1949–1955
- Schlaich C, Minne H W, Bruckner T. Reduced pulmonary function in patients with spinal osteoporotic fractures. Osteoporos Int 1998; 8(3)261–267
- Papaioannou A, Parkinson W, Ferko N, Probyn L. Prevalence of vertebral fractures among patients with chronic obstructive pulmonary disease in Canada. Osteoporos Int 2003; 14(11)913–917